test44
https://www.cytel.com/blog/a-conversation-with-malte-stein
November 9, 2022
In this edition of the Career Perspectives series, I interview Malte Stein, Senior Biostatistician. Malte owned the..
Read article
test44
https://www.cytel.com/blog/interview-with-nicolas-rouillé
October 14, 2022
In this edition of the Career Perspectives series, I interview Nicolas Rouillé, Senior Director, Statistical..
Read article
test44
https://www.cytel.com/blog/career-perspectives-interview-with-allison-luccock-director-rwaa-business-operations
August 4, 2022
In this edition of the Career Perspectives series, I interview Allison Luccock, Director of Business Operations for..
Read article
test44
https://www.cytel.com/blog/driving-global-data-collaboration-for-covid-19
June 13, 2022
The International COVID-19 Data Alliance (ICODA) was formed to address the challenge of generating rapid and rigorous..
Read article
test44
https://www.cytel.com/blog/the-together-trial-journey-interview-with-ofir-harari
June 6, 2022
The award-winning TOGETHER Trial was designed with the vision of ensuring that COVID-19 therapies are both effective..
Read article
test44
https://www.cytel.com/blog/together-trial-wins-the-sct-trial-of-the-year-award-interview-with-hinda-ruton
May 31, 2022
The TOGETHER Trial for COVID-19 therapies, designed by clinical trial specialists at Cytel won the Society for Clinical..
Read article
test44
https://www.cytel.com/blog/leveraging-advanced-statistical-software-to-optimize-clinical-development
May 24, 2022
Traditionally, clinical trials are expensive, long in duration, and have low success rate. But with the advent of rich..
Read article
test44
https://www.cytel.com/blog/estimator-choice-in-synthetic-control-arm-analyses-an-ispor-podium-presentation-by-cytel
May 12, 2022
Synthetic control arm (SCA) methods are statistical methods that are seeing rapidly increasing use in comparative..
Read article
test44
https://www.cytel.com/blog/an-interview-with-grammati-sarri-on-moderating-an-issue-panel-at-ispor-us-2022-0
May 5, 2022
While randomized control trials remain the industry gold-standard for regulatory and reimbursement submissions, there..
Read article
